These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11450899)

  • 1. Interferon-alpha 2a treatment of neuro-Behcet disease.
    Nichols JC; Ince A; Akduman L; Mann ES
    J Neuroophthalmol; 2001 Jun; 21(2):109-11. PubMed ID: 11450899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.
    Alpsoy E; Durusoy C; Yilmaz E; Ozgurel Y; Ermis O; Yazar S; Basaran E
    Arch Dermatol; 2002 Apr; 138(4):467-71. PubMed ID: 11939808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-Behçet disease presenting with acute psychosis in an adolescent.
    Patel P; Steinschneider M; Boneparth A; Lantos G
    J Child Neurol; 2014 Sep; 29(9):NP86-91. PubMed ID: 24092890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-Behçet syndrome presenting as acute meningeal syndrome.
    Kara B; Somer A; Pişkin S; Aydinli N; Salman N; Yalçin I
    J Infect; 2006 Apr; 52(4):e120-3. PubMed ID: 16197999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic Adamantiades-Behçet's disease: adverse effects of an otherwise successful therapy with interferon-α-2a].
    Karagiannidis I; Zouboulis CC
    Dtsch Med Wochenschr; 2015 Jan; 140(2):112-3. PubMed ID: 25612283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Pegylated Interferon Alpha-2a in Behçet Uveitis: A Report of Five Cases.
    Bielefeld P; Devilliers H; Deschasse C; Saadoun D; Sève P; Muselier A; Creuzot-Garcher C; Besancenot JF; Bron AM
    Ocul Immunol Inflamm; 2016 Oct; 24(5):599-602. PubMed ID: 25760915
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
    Zouboulis CC; Orfanos CE
    Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and Treatment of Neuro-Behçet: A Clinical Update].
    Silva L; Correia J; Santos E
    Acta Med Port; 2023 Sep; 36(9):588-594. PubMed ID: 37345389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis.
    Onal S; Kazokoglu H; Koc A; Akman M; Bavbek T; Direskeneli H; Yavuz S
    Arch Ophthalmol; 2011 Mar; 129(3):288-94. PubMed ID: 21402983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumoral Behçet's disease.
    Alonso S; Riveros-Frutos A; Martínez-Morillo M; Grau-Ferrer L; Carrato C; Olivé A
    Reumatol Clin; 2016; 12(2):85-90. PubMed ID: 26078022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients.
    Lee JH; Lee CS; Lee SC
    BMC Ophthalmol; 2018 Feb; 18(1):52. PubMed ID: 29463220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive MRI lesion in brain stem of a neuro-Behcet patient.
    Kurne A; Arsava EM; Turkmen I; Firat MM; Kansu T
    Eur J Neurol; 2003 May; 10(3):325-6. PubMed ID: 12752409
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.
    Kötter I; Vonthein R; Zierhut M; Eckstein AK; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Stübiger N
    Semin Arthritis Rheum; 2004 Apr; 33(5):311-9. PubMed ID: 15079762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serial MRI findings in neuro-Behçet disease].
    Yamashita Y; Ikeda Y; Tajima H; Okada K; Nakazawa S
    No Shinkei Geka; 1992 Dec; 20(12):1295-9. PubMed ID: 1484598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging of neuro-Behcet].
    Oueslati S; Douira W; Charrada-Ben Farhat L; Chatti K; Rezgui L; Ben Abdallah N; Bouhaouala MH; Chaabene M
    Tunis Med; 2005 Nov; 83(11):681-4. PubMed ID: 16422366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.
    Hasanreisoglu M; Cubuk MO; Ozdek S; Gurelik G; Aktas Z; Hasanreisoglu B
    Ocul Immunol Inflamm; 2017 Feb; 25(1):71-75. PubMed ID: 26910383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches in the treatment of Adamantiades-Behçet's disease.
    Pipitone N; Olivieri I; Cantini F; Triolo G; Salvarani C
    Curr Opin Rheumatol; 2006 Jan; 18(1):3-9. PubMed ID: 16344613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.